BACKGROUND: In the United States, injection is an increasingly common route of administration for opioids and other substances. Estimates of the number of persons who inject drugs (PWID) are needed for monitoring risk-specific infectious disease rates and health services coverage. METHODS: We reviewed design and instruments for 4 national household surveys, 2012-2016, for their ability to produce unbiased injection drug use (IDU) prevalence estimates. We explored potential analytic adjustments for reducing biases through use of external data on (1) arrest, (2) narcotic overdose mortality, and (3) biomarker-based sensitivity of self-reported illicit drug use. RESULTS: Estimated national past 12 months IDU prevalence ranged from 0.24% to 0.59% across surveys. All surveys excluded unstably housed and incarcerated persons, and estimates were based on <60 respondents reporting IDU behavior in 3 surveys. No surveys asked participants about nonmedical injection of prescription drugs. Analytic adjustments did not appreciably change IDU prevalence estimates due to suboptimal specificity of data points. CONCLUSIONS: PWID population size estimates in the United States are based on small numbers and are likely biased by undercoverage of key populations and self-report. Novel methods as discussed in this article may improve our understanding of PWID population size and their health needs.
BACKGROUND: In the United States, injection is an increasingly common route of administration for opioids and other substances. Estimates of the number of persons who inject drugs (PWID) are needed for monitoring risk-specific infectious disease rates and health services coverage. METHODS: We reviewed design and instruments for 4 national household surveys, 2012-2016, for their ability to produce unbiased injection drug use (IDU) prevalence estimates. We explored potential analytic adjustments for reducing biases through use of external data on (1) arrest, (2) narcotic overdosemortality, and (3) biomarker-based sensitivity of self-reported illicit drug use. RESULTS: Estimated national past 12 months IDU prevalence ranged from 0.24% to 0.59% across surveys. All surveys excluded unstably housed and incarcerated persons, and estimates were based on <60 respondents reporting IDU behavior in 3 surveys. No surveys asked participants about nonmedical injection of prescription drugs. Analytic adjustments did not appreciably change IDU prevalence estimates due to suboptimal specificity of data points. CONCLUSIONS: PWID population size estimates in the United States are based on small numbers and are likely biased by undercoverage of key populations and self-report. Novel methods as discussed in this article may improve our understanding of PWID population size and their health needs.
Authors: Alysse G Wurcel; Jordan E Anderson; Kenneth K H Chui; Sally Skinner; Tamsin A Knox; David R Snydman; Thomas J Stopka Journal: Open Forum Infect Dis Date: 2016-07-26 Impact factor: 3.835
Authors: Jeoungbin Choi; Moran Ki; Ho Jang Kwon; Boyoung Park; Sanghyuk Bae; Chang-Mo Oh; Byung Chul Chun; Gyung-Jae Oh; Young Hoon Lee; Tae-Yong Lee; Hae Kwan Cheong; Bo Youl Choi; Jung Han Park; Sue K Park Journal: J Prev Med Public Health Date: 2019-01-23
Authors: Sarah Larney; Matthew Hickman; Rebecca Guy; Jason Grebely; Gregory J Dore; Richard T Gray; Carolyn A Day; Jo Kimber; Louisa Degenhardt Journal: BMC Public Health Date: 2017-09-29 Impact factor: 3.295
Authors: Megan C Kelly; Samantha D Yeager; Mahmoud A Shorman; Laurence R Wright; Michael P Veve Journal: Antimicrob Agents Chemother Date: 2021-09-20 Impact factor: 5.191
Authors: Robert L Cooper; Paul D Juarez; Matthew C Morris; Aramandla Ramesh; Ryan Edgerton; Lauren L Brown; Leandro Mena; Samuel A MacMaster; Shavonne Collins; Patricia Matthews- Juarez; Mohammad Tabatabai; Katherine Y Brown; Michael J Paul; Wansoo Im; Thomas A Arcury; Marybeth Shinn Journal: Inquiry Date: 2021 Jan-Dec Impact factor: 1.730
Authors: James Wilton; Younathan Abdia; Mei Chong; Mohammad Ehsanul Karim; Stanley Wong; Aaron MacInnes; Rob Balshaw; Bin Zhao; Tara Gomes; Amanda Yu; Maria Alvarez; Richard C Dart; Mel Krajden; Jane A Buxton; Naveed Z Janjua; Roy Purssell Journal: BMJ Date: 2021-11-18